BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, ...
PLEASANTON, Calif., Oct. 13, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced two new Veeva Link applications to help clinical teams improve site selection and optimize trial design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results